Modifying the sugar icing on the transplantation cake
Open accessThe DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
As a transplant surgeon, my interest in glycobiology began through my research into ABO-incompatible allotransplantation, and grew when my goal became overcoming the shortage of organs from deceased human donors by the transplantation of pig organs into patients with terminal organ failure (xenotransplantation/cross-species transplantation). The major target for human "natural" (preformed) anti-pig antibodies is galactose-α(1,3)-galactose (the "Gal" epitope), which is expressed on many pig cells, including the vascular endothelium. The binding of human IgM and IgG antibodies to Gal antigens initiates the process of hyperacute rejection, resulting in destruction of the pig graft within minutes or hours. This major barrier has been overcome by the production of pigs in which the gene for the enzyme α(1,3)-galactosyltransferase (GT) has been deleted by genetic engineering, resulting in GT knockout (GTKO) pigs. The two other known carbohydrate antigenic targets on pig cells for human anti-pig antibodies are (i) the product of the cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH) gene, i.e., N-glycolylneuraminic acid, and (ii) the product of the β1,4 N-acetylgalactosaminyltransferase gene, i.e., the Sd(a) antigen. Expression of these two has also been deleted in pigs. These genetic manipulations, together with others directed to overcoming primate complement and coagulation activation (the latter of which also relates to glycobiology) have contributed to the prolongation of pig graft survival in nonhuman primate recipients to many months rather than a few minutes. Clinical trials of the transplantation of pig cells are already underway and transplantation of pig organs may be expected within the relatively near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“glycans like ɑ -Gal and the nonhuman sialic acid Neu5Gc represent the major xenoantigens that must be bypassed, to pursue the goal of xeno- (pig organ) transplantation into humans. In pursuit of this dif fi cult goal, ɑ -Galand Neu5Gc-double null pigs have recently been generated (980 -983).”
From Biological roles of glycans (2017) · cites this paper as [983]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheep cloned by nuclear transfer from a cultured cell line
Campbell, K. H. S., McWhir, J., Ritchie, W. A., & Wilmut, I. (1996) · Nature · doi:10.1038/380064a0 · Cited by 1,844 · cited 3×
“1996), but knockout of the GT gene in pigs only became possible after the development of the technology that produced the world’s first cloned mammal, the sheep known as “Dolly” (Campbell et al. 1996) and, subsequently, the first cloned pig (Polejaeva et al.”
BackgroundCloned pigs produced by nuclear transfer from adult somatic cells
Polejaeva, I. A., Chen, S.-H., Vaught, T. D., Page, R. L., Mullins, J., Ball, S., Dai, Y., Boone, J., Walker, S., Ayares, D. L., et al. (2000) · Nature · doi:10.1038/35024082 · Cited by 1,254 · cited 2×
“1996) and, subsequently, the first cloned pig (Polejaeva et al. 2000).”
BackgroundProduction of α1,3-Galactosyltransferase-Deficient Pigs
Phelps, C. J., Koike, C., Vaught, T. D., Boone, J., Wells, K. D., Chen, S.-H., Ball, S., Specht, S. M., Polejaeva, I. A., Monahan, J. A., et al. (2003) · Science · doi:10.1126/science.1078942 · Cited by 1,112 · cited 1×
“The first GTKO pigs did not become available until 2003 (Phelps et al. 2003; Kolber-Simonds et al. 2004), and my colleagues and I at the TBRCwere the first to test the transplantation of organs from these pigs in immunosuppressed baboons (Kuwaki et al. 2005; Tseng et al. 2005a; Yamada et al. 2005;…”
BackgroundGalili, U., Shohet, S. B., Kobrin, E., Stults, C. L., & Macher, B. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77900-9 · Cited by 817
Kuwaki, K., Tseng, Y.-L., Dor, F. J. M. F., Shimizu, A., Houser, S. L., Sanderson, T. M., Lancos, C. J., Prabharasuth, D. D., Cheng, J., Moran, K., et al. (2005) · Nature Medicine · doi:10.1038/nm1171 · Cited by 694 · cited 1×
“…until 2003 (Phelps et al. 2003; Kolber-Simonds et al. 2004), and my colleagues and I at the TBRCwere the first to test the transplantation of organs from these pigs in immunosuppressed baboons (Kuwaki et al. 2005; Tseng et al. 2005a; Yamada et al. 2005; Hisashi et al. 2008; Shimizu et al. 2008).”
BackgroundSelf-citationGalili, U. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90261-i · Cited by 659 · cited 1×
“Although Galili had carried out several studies on the nature of anti-Gal antibodies, he had not directed his attention towards xenotransplantation before this time (Galili 1993).”
BackgroundGood, A. H., Cooper, D. K. C., Malcolm, A. J., Ippolito, R. M., Koren, E., Neethling, F. A., YE, Y., Zuhdi, N., & Lamontagne, L. R. (1992) · PubMed · Cited by 639
Self-citationA unique natural human IgG antibody with anti-alpha-galactosyl specificity.
Galili, U., Rachmilewitz, E. A., Peleg, A., & Flechner, I. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1519 · Cited by 631 · cited 2×
“I had never heard of Gal previously, but the Chembiomed team informed me that they had prior knowledge of it as they had carried out some work for Uri Galili, who had identified that all mammals below Old World monkeys express Gal whereas Old World nonhuman primates and humans lack the requisite enzyme α(1,3)galactosy…”
BackgroundYamada, K., Yazawa, K., Shimizu, A., Iwanaga, T., Hisashi, Y., Nuhn, M., O'Malley, P., Nobori, S., Vagefi, P. A., Patience, C., et al. (2005) · Nature Medicine · doi:10.1038/nm1172 · Cited by 610 · cited 2×
“2004), and my colleagues and I at the TBRC were the first to test the transplantation of organs from these pigs in immunosuppressed baboons (Kuwaki et al. 2005; Tseng et al. 2005a; Yamada et al. 2005; Hisashi et al. 2008; Shimizu et al. 2008).”
BackgroundSelf-citationAnti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes.
Sandrin, M. S., Vaughan, H. A., Dabkowski, P. L., & McKenzie, I. F. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11391 · Cited by 605 · cited 1×
“Others soon confirmed our conclusion (Sandrin et al. 1993).”
Research works printed but not linked: 3
- Cooper DKC. 1991. Allo- and xeno- transplantation in non-human primates. Minerva Chirurgica. 46(Suppl. 1 al N. 11):107–116. [Google Scholar]
- Cooper DK, Cairns TD, Taube DH. 1996a. Extracorporeal immunoadsorption of alphaGal antibodies. Xeno. 4:27–29. [Google Scholar]
- Galili U. 1998. Anti-gal antibody prevents xenotransplantation. Sci Med. 5:28–37. [Google Scholar]
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“In pursuit of this difficult goal, ɑ-Galand Neu5Gc-double null pigs have recently been generated (980) (981) (982) (983) .”
BackgroundLong-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion
Kim, S. C., Mathews, D. V., Breeden, C. P., Higginbotham, L. B., Ladowski, J., Martens, G., Stephenson, A., Farris, A. B., Strobert, E. A., Jenkins, J., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15329 · Cited by 232
Extensive germline genome engineering in pigs
Yue, Y., Xu, W., Kan, Y., Zhao, H.-Y., Zhou, Y., Song, X., Wu, J., Xiong, J., Goswami, D., Yang, M., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00613-9 · Cited by 172
Xenotransplantation: past, present, and future
Ekser, B., Li, P., & Cooper, D. K. C. (2017) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000463 · Cited by 112
“Cooper recently published a review on carbohydrate antigen targets on pig cells [101].”
BackgroundSelf-citationThe Role of SLAs in Xenotransplantation
Ladowski, J. M., Hara, H., & Cooper, D. K. C. (2020) · Transplantation · doi:10.1097/tp.0000000000003303 · Cited by 55
Self-citation
Metadata
- Authors
- Cooper, D. K. C.
- Affiliations
- University of Pittsburgh Medical Center (US)
- Corresponding author
- Cooper, David K C
- ORCID
- Cooper, David K C
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-03-01
- Volume
- 26
- Issue
- 6
- Pages
- 571-581
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- PMC
- PMC4847619
- OpenAlex
- W2291937681
- Cited by
- 36
- References
- 122
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 4 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 2 · 2017: 6 · 2016: 1
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Glycobiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- NIH (U01 AI068642, R21 AI074844, U19 AI090959)
- University of Pittsburgh
- Revivicor, Inc., Blacksburg, VA
- Topics
- Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
- Keywords
- xenotransplantation, pig-to-human xenotransplantation, anti-pig antibodies, hyperacute rejection, N-glycolylneuraminic acid, complement activation, coagulation activation, organ shortage
- MeSH terms
- Animals, Antigens, Galactosyltransferases, Graft Rejection, Graft Survival, Humans, Mixed Function Oxygenases, Immunoglobulin G, Immunoglobulin M, Papio, Swine, Transplantation, Heterologous, Transplantation, Homologous, Gene Expression, Organ Transplantation, Gene Deletion, Animals, Genetically Modified
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modifying the sugar icing on the transplantation cake. https://app.cochat.ai/papers/10.1093/glycob/cww028
- The paper
- Cooper, D. K. C. (2016). Modifying the sugar icing on the transplantation cake. Glycobiology. https://doi.org/10.1093/glycob/cww028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.